C181 (Rizatriptan benzoate 5 mg (base))
This pill with imprint "C181" is Pink, Elliptical / Oval and has been identified as Rizatriptan benzoate 5 mg (base). It is supplied by Cipla USA Inc..
Rizatriptan is used in the treatment of migraine and belongs to the drug class antimigraine agents. Risk cannot be ruled out during pregnancy. Rizatriptan 5 mg (base) is not a controlled substance under the Controlled Substance Act (CSA).
Rizatriptan benzoate
- Imprint:
- C181
- Strength:
- 5 mg (base)
- Color:
- Pink
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Antimigraine agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Cipla USA Inc.
- National Drug Code (NDC):
- 69097-0181
More about rizatriptan
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 207 Reviews – Add your own review/rating
- Drug class: antimigraine agents
Consumer resources
- Rizatriptan Tablets
- Rizatriptan Orally Disintegrating Tablets
- Rizatriptan
- Rizatriptan (Advanced Reading)
Other brands: Maxalt, Maxalt-MLT
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
